Enroll-HD
Clinical Research
A collaboration between Huntington’s disease families, clinicians, and researchers to accelerate progress toward effective treatments.
Current Participants
Your information is powerful! Learn about current research opportunities.
Enroll-HD
Clinical research platform
Enroll-HD is a clinical research platform and the world’s largest observational study for Huntington’s disease families. It is a resource for the entire HD community, including families, clinicians, researchers, advocates, and anyone else who has a connection to or an interest in HD.
A platform for the whole HD community.
Current Participants
Clinical Sites Worldwide
Nations Participating
Enroll-HD: Jan 1, 2023 data cut
Contact us for trial support
Send us a message. An Enroll-HD team member will get back to you as soon as possible.
Enroll-HD
News
New Enroll-HD periodic dataset (PDS6) now available!
New Enroll-HD periodic dataset (PDS6)...
Disappointing news from Novartis about branaplam and the VIBRANT-HD trial
The pharmaceutical company Novartis has...
uniQure gets the green light to resume testing HD gene therapy
In August 2022, uniQure announced...
Update on the PTC Therapeutics PIVOT-HD Trial
Recruitment of participants into the...
European Medicines Agency issues qualification opinion that Enroll-HD can provide data and infrastructure support for post-authorization monitoring of medical products for Huntington’s disease
European Medicines Agency issues qualification opinion that Enroll-HD can provide...
